✦ LIBER ✦

334 – Long-term safety/tolerability of paliperidone extended-release tablets: 52-week, open-label extension study

✍ Scribed by M. Kramer; G. Simpson; S. Kushner; Y. Liu; P. Lim; D. Hough; M. Eerdekens; J. Palumbo

Book ID: 119363757
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 98
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2007.12.401

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 52-week open-label study of the safety

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

✍ Gopal, S.; Vijapurkar, U.; Lim, P.; Morozova, M.; Eerdekens, M.; Hough, D. 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 288 KB

Safety and Tolerability of Oral Paliperi

Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension

✍ Tzimos, Andreas; Samokhvalov, Viktor; Kramer, Michelle; Ford, Lisa; Gassmann-May 📂 Article 📅 2008 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 150 KB

(456) Effectiveness and safety of oxycod

(456) Effectiveness and safety of oxycodone/naloxone controlled release tablets during three 52-week open-label extension studies

✍ Moline, M.; Berger, B.; Dain, B.; Munera, C.; Hopp, M.; Green, J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Opioids in non-cancer pain: Open-label,

Opioids in non-cancer pain: Open-label, long-term extension study of tolerability, safety, and effectiveness of oxymorphone extended release for low back pain

✍ M. Hale; M. Tark 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A 52-week open-label study of the long-t

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

✍ Diego Garcia-Borreguero; Ronald Grunstein; Guruswamy Sridhar; Tilman Dreykluft; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Long-Term Safety and Efficacy of Donepez

Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

✍ Ikeda, Manabu; Mori, Etsuro; Kosaka, Kenji; Iseki, Eizo; Hashimoto, Mamoru; Mats 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 856 KB